{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:18:41Z","timestamp":1792099121813,"version":"4.4.0"},"update-to":[{"DOI":"10.1002\/14651858.cd013011","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,1,18]],"date-time":"2021-01-18T00:00:00Z","timestamp":1610928000000}}],"reference-count":145,"publisher":"Wiley","issue":"1","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd013011.pub2","type":"journal-article","created":{"date-parts":[[2021,1,18]],"date-time":"2021-01-18T12:37:10Z","timestamp":1610973430000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults"],"prefix":"10.1002","volume":"2021","author":[{"given":"Raissa Carolina F","family":"C\u00e2ndido","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy; Universidade Federal de Minas Gerais (UFMG); Belo Horizonte Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiane A","family":"Menezes de Padua","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy; Universidade Federal de Minas Gerais (UFMG); Belo Horizonte Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su","family":"Golder","sequence":"additional","affiliation":[{"name":"Department of Health Sciences; University of York; York UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela R","family":"Junqueira","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Dentistry; University of Alberta; Edmonton Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,1,18]]},"reference":[{"issue":"8","key":"10.1002\/14651858.CD013011.pub2-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1177\/070674370304800806","article-title":"The efficacy of 2 different dosages of methylphenidate in treating adults with attention-deficit hyperactivity disorder","volume":"48","author":"Bouffard","year":"2003","journal-title":"Canadian Journal of Psychiatry [Revue Canadienne de Psychiatrie]"},{"issue":"12","key":"10.1002\/14651858.CD013011.pub2-BIB0002|cit2","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1111\/j.1360-0443.2005.01272.x","article-title":"A controlled trial of methylphenidate in adults with attention deficit\/hyperactivity disorder and substance use disorders","volume":"100","author":"Carpentier","year":"2005","journal-title":"Addiction"},{"issue":"3","key":"10.1002\/14651858.CD013011.pub2-BIB0003|cit3","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1176\/jnp.14.3.289","article-title":"A randomized, double-blind, crossover study of methylphenidate and lithium in adults with attention-deficit\/hyperactivity disorder: preliminary findings","volume":"14","author":"Dorrego","year":"2002","journal-title":"Journal of Neuropsychiatry and Clinical Neurosciences"},{"issue":"6","key":"10.1002\/14651858.CD013011.pub2-BIB0004|cit4","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1017\/s0033291703001776","article-title":"Efficacy and safety of methylphenidate in 45 adults with attention-deficit\/hyperactivity disorder. A randomized placebo-controlled double-blind cross-over trial","volume":"34","author":"Kooij","year":"2004","journal-title":"Psychological Medicine"},{"issue":"3","key":"10.1002\/14651858.CD013011.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3109\/10401230109148958","article-title":"Bupropion SR vs methylphenidate vs placebo for attention deficit hyperactivity disorder in adults","volume":"13","author":"Kuperman","year":"2001","journal-title":"Annals of Clinical Psychiatry"},{"issue":"9","key":"10.1002\/14651858.CD013011.pub2-BIB0006|cit6","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1001\/jamapsychiatry.2016.1572","article-title":"Age-dependent effects of methylphenidate on the human dopaminergic system in young vs adult patients with attention-deficit\/hyperactivity disorder: a randomized clinical trial","volume":"73","author":"Schrantee","year":"2016","journal-title":"JAMA Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD013011.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1037\/1064-1297.10.3.286","article-title":"Double-blind placebo-controlled trial of methylphenidate in the treatment of adult ADHD patients with comorbid cocaine dependence","volume":"10","author":"Schubiner","year":"2002","journal-title":"Experimental and Clinical Psychopharmacology"},{"issue":"5","key":"10.1002\/14651858.CD013011.pub2-BIB0008|cit8","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.biopsych.2004.11.043","article-title":"A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit\/hyperactivity disorder","volume":"57","author":"Spencer","year":"2005","journal-title":"Biological Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD013011.pub2-BIB0009|cit9","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1177\/1087054710367880","article-title":"A randomized, single-blind, substitution study of OROS methylphenidate (Concerta) in ADHD adults receiving immediate release methylphenidate","volume":"15","author":"Spencer","year":"2011","journal-title":"Journal of Attention Disorders"},{"issue":"2","key":"10.1002\/14651858.CD013011.pub2-BIB0010|cit10","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1177\/108705470200600201","article-title":"An experimental comparison of Pycnogenol and methylphenidate in adults with attention-deficit\/hyperactivity disorder (ADHD)","volume":"6","author":"Tenenbaum","year":"2002","journal-title":"Journal of Attention Disorders"},{"issue":"1","key":"10.1002\/14651858.CD013011.pub2-BIB0011|cit11","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1148\/radiol.2019182528","article-title":"White matter by diffusion MRI following methylphenidate treatment: a randomized control trial in males with attention-deficit\/hyperactivity disorder","volume":"293","author":"Bouziane","year":"2019","journal-title":"Radiology"},{"key":"10.1002\/14651858.CD013011.pub2-BIB0012|cit12","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/1471-244X-11-116","article-title":"Cognitive behaviour therapy in medication-treated adults with ADHD and persistent symptoms: a randomized controlled trial","volume":"11","author":"Emilsson","year":"2011","journal-title":"BMC Psychiatry"},{"key":"10.1002\/14651858.CD013011.pub2-BIB0013|cit13","unstructured":"Saffron for attention deficit hyperactivity disorder in adults www.who.int\/trialsearch\/Trial2.aspx?TrialID=IRCT20090117001556N111"},{"key":"10.1002\/14651858.CD013011.pub2-BIB0014|cit14","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/j.1749-6632.2001.tb05785.x","article-title":"Adult ADHD. Controlled medication assessment","volume":"931","author":"Kinsbourne","year":"2001","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"11","key":"10.1002\/14651858.CD013011.pub2-BIB0015|cit15","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1001\/archpsyc.1983.01790220049008","article-title":"Methylphenidate effects on symptoms of attention deficit disorder in adults","volume":"41","author":"Mattes","year":"1984","journal-title":"Archives of General Psychiatry"},{"issue":"8","key":"10.1002\/14651858.CD013011.pub2-BIB0016|cit16","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1002\/ajmg.b.30376","article-title":"Absence of association with DAT1 polymorphism and response to methylphenidate in a sample of adults with ADHD","volume":"141B","author":"Mick","year":"2006","journal-title":"American Journal of Medical Genetics. Part B. Neuropsychiatric Genetics"},{"key":"10.1002\/14651858.CD013011.pub2-BIB0017|cit17","unstructured":"Effects of expectation, medication and placebo on objective and self-rated performance clinicaltrials.gov\/ct2\/show\/NCT02477280"},{"issue":"9","key":"10.1002\/14651858.CD013011.pub2-BIB0018|cit18","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1017\/S1461145713000357","article-title":"A head-to-head randomized clinical trial of methylphenidate and atomoxetine treatment for executive function in adults with attention-deficit hyperactivity disorder","volume":"16","author":"Ni","year":"2013","journal-title":"International Journal of Neuropsychopharmacology"},{"issue":"5","key":"10.1002\/14651858.CD013011.pub2-BIB0019|cit19","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1177\/0269881116632377","article-title":"Atomoxetine could improve intra-individual variability in drug-na\u00efve adults with attention-deficit\/hyperactivity disorder comparably with methylphenidate: a head-to-head randomized clinical trial","volume":"30","year":"2016","journal-title":"Journal of Psychopharmacology"},{"issue":"512","key":"10.1002\/14651858.CD013011.pub2-BIB0020|cit20","first-page":"175","article-title":"Using n-of-1 trials as a clinical tool to improve prescribing","volume":"55","author":"Nikles","year":"2005","journal-title":"British Journal of General Practice"},{"issue":"7","key":"10.1002\/14651858.CD013011.pub2-BIB0021|cit21","doi-asserted-by":"publisher","first-page":"A403","DOI":"10.1016\/j.jval.2011.08.933","article-title":"The cost effectiveness of clinically proven treatment strategies for attention-deficit\/hyperactivity disorder (ADHD) in adult patients","volume":"14","author":"Schlander","year":"2011","journal-title":"Value in Health"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD013011.pub2-BIB0022|cit22","first-page":"S442","article-title":"Efficacy in a 6-month trial of methylphenidate in adults with attention-deficit hyperactivity disorder","volume":"7","author":"Spencer","year":"2004","journal-title":"International Journal of Neuropsychopharmacology"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD013011.pub2-BIB0023|cit23","doi-asserted-by":"publisher","first-page":"S369","DOI":"10.1016\/S0924-977X(04)80533-9","article-title":"Efficacy in a 5 month trial of methylphenidate in adults with attention-deficit hyperactivity disorder","volume":"14","author":"Spencer","year":"2004","journal-title":"European Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD013011.pub2-BIB0024|cit24","unstructured":"Spencer TJ Preliminary results of a six month trial of methylphenidate in adults with ADHD The Promise of Science. The Power of Healing. 156th Annual Meeting of the American Psychiatric Association; 2003 May 17 - 22; San Francisco (CA) San Francisco (CA) American Psychiatric Association 2003 56"},{"issue":"2","key":"10.1002\/14651858.CD013011.pub2-BIB0025|cit25","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s00213-011-2328-y","article-title":"Methylphenidate increases cigarette smoking in participants with ADHD","volume":"218","author":"Vansickel","year":"2011","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD013011.pub2-BIB0026|cit26","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1177\/0269881107082946","article-title":"Methylphenidate significantly improves driving performance of adults with attention-deficit hyperactivity disorder: a randomized crossover trial","volume":"22","author":"Verster","year":"2008","journal-title":"Journal of Psychopharmacology"},{"key":"10.1002\/14651858.CD013011.pub2-BIB0027|cit27","unstructured":"Wender PH Reimherr FW Marchan B Czajkowski L Sanford E A placebo-controlled, long-term trial of methylphenidate in the treatment of adults with ADHD American Psychiatric Association Mind Meets Brain: Integrating Psychiatry, Psychoanalysis, Neuroscience. American Psychiatric Association 2001 Annual Meeting, Proceedings Summary; 2001 May 5-10; New Orleans (LA) New Orleans (LA) 2001 43"},{"key":"10.1002\/14651858.CD013011.pub2-BIB0028|cit28","unstructured":"Wender PH A placebo controlled, long-term trial of methylphenidate in the treatment of adults with ADHD CENTRAL 2001"},{"issue":"12","key":"10.1002\/14651858.CD013011.pub2-BIB0029|cit29","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1001\/archpsyc.1976.01770120057005","article-title":"Diagnosis and treatment of minimal brain dysfunction in adults: a preliminary report","volume":"33","author":"Wood","year":"1976","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD013011.pub2-BIB0030|cit30","unstructured":"Comparison of the effectiveness of methylphenidate and atomoxetine in the treatment of attention deficit hyperactivity disorder in adult patients apps.who.int\/trialsearch\/Trial2.aspx?TrialID=IRCT20110802007202N15"},{"key":"10.1002\/14651858.CD013011.pub2-BIB0031|cit31","unstructured":"The effects of Ritalin treatment on decision making and learning, and on brain activation, in adult ADHD www.clinicaltrialsregister.eu\/ctr-search\/trial\/2012-005246-38\/NO"},{"issue":"7","key":"10.1002\/14651858.CD013011.pub2-BIB0032|cit32","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1001\/jamapsychiatry.2016.0465","article-title":"Evaluation of the persistence, remission, and emergence of attention-deficit\/hyperactivity disorder in young adulthood","volume":"73","author":"Agnew-Blais","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"10.1002\/14651858.CD013011.pub2-BIB0033|cit33","volume-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-III)","author":"American Psychiatric Association","year":"1980"},{"key":"10.1002\/14651858.CD013011.pub2-BIB0034|cit34","volume-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-III-R)","author":"American Psychiatric Association","year":"1987"},{"key":"10.1002\/14651858.CD013011.pub2-BIB0035|cit35","volume-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)","author":"American Psychiatric Association","year":"1994"},{"key":"10.1002\/14651858.CD013011.pub2-BIB0036|cit36","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-5)","author":"American Psychiatric Association","year":"2013"},{"key":"10.1002\/14651858.CD013011.pub2-BIB0037|cit37","unstructured":"American Psychiatric Association What is ADHD? www.psychiatry.org\/patients-families\/adhd\/what-is-adhd 2017"},{"key":"10.1002\/14651858.CD013011.pub2-BIB0038|cit38","volume-title":"Attention Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment","author":"Barkley","year":"1990"},{"key":"10.1002\/14651858.CD013011.pub2-BIB0039|cit39","doi-asserted-by":"crossref","DOI":"10.1038\/scientificamerican0998-66","volume-title":"Attention-Deficit Hyperactivity Disorder: A Clinical Workbook","author":"Barkley","year":"1998"},{"issue":"19","key":"10.1002\/14651858.CD013011.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1001\/jama.279.19.1566","article-title":"Why review articles on the health effects of passive smoking reach different conclusions","volume":"279","author":"Barnes","year":"1998","journal-title":"JAMA"},{"issue":"17","key":"10.1002\/14651858.CD013011.pub2-BIB0041|cit41","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1001\/jama.2017.3854","article-title":"Addressing bias and conflict of interest among biomedical researchers","volume":"317","author":"Bero","year":"2017","journal-title":"JAMA"},{"issue":"12","key":"10.1002\/14651858.CD013011.pub2-BIB0042|cit42","doi-asserted-by":"publisher","first-page":"e1001578; discu","DOI":"10.1371\/journal.pmed.1001578","article-title":"Financial conflicts of interest and reporting bias regarding the association between sugar-sweetened beverages and weight gain: a systematic review of systematic reviews","volume":"10","author":"Bes-Rastrollo","year":"2013","journal-title":"PLOS Med"},{"issue":"11","key":"10.1002\/14651858.CD013011.pub2-BIB0043|cit43","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012857","article-title":"Extended-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults","author":"Boesen","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD013011.pub2-BIB0044|cit44","unstructured":"Boutron I Page MJ Higgins JP Altman DG Lundh A Hr\u00f3bjartsson A Chapter 7: Considering bias and conflicts of interest among the included studies. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.1 (updated September 2020). Cochrane, 2020 Available from www.training.cochrane.org\/handbook"},{"issue":"3","key":"10.1002\/14651858.CD013011.pub2-BIB0045|cit45","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1176\/ajp.94.3.577","article-title":"The behavior of children receiving benzedrine","volume":"94","author":"Bradley","year":"1937","journal-title":"American Journal of Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD013011.pub2-BIB0046|cit46","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1177\/0269881116636105","article-title":"A network meta-analysis of atomoxetine and osmotic release oral system methylphenidate in the treatment of attention-deficit\/hyperactivity disorder in adult patients","volume":"30","author":"Bushe","year":"2016","journal-title":"Journal of Psychopharmacology"},{"key":"10.1002\/14651858.CD013011.pub2-BIB0047|cit47","volume-title":"CADDRA","year":"2020"},{"issue":"2","key":"10.1002\/14651858.CD013011.pub2-BIB0048|cit48","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2165\/11539440-000000000-00000","article-title":"Efficacy of methylphenidate for adults with attention-deficit hyperactivity disorder: a meta-regression analysis","volume":"25","author":"Castells","year":"2011","journal-title":"CNS Drugs"},{"issue":"8","key":"10.1002\/14651858.CD013011.pub2-BIB0049|cit49","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007813.pub3","article-title":"Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults","author":"Castells","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD013011.pub2-BIB0050|cit50","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1001\/jamapsychiatry.2016.0383","article-title":"Attention-deficit hyperactivity disorder trajectories from childhood to young adulthood: evidence from a birth cohort supporting a late-onset syndrome","volume":"73","author":"Caye","year":"2016","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD013011.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1542\/peds.72.1.56","article-title":"Methylphenidate hydrochloride given with or before breakfast: effects on plasma concentration of methylphenidate and ritalinic acid","volume":"72","author":"Chan","year":"1983","journal-title":"Pediatrics"},{"issue":"1","key":"10.1002\/14651858.CD013011.pub2-BIB0052|cit52","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jaac.2010.09.019","article-title":"Childhood attention-deficit hyperactivity disorder and future substance use disorders: comparative meta-analyses","volume":"50","author":"Charach","year":"2011","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD013011.pub2-BIB0053|cit53","doi-asserted-by":"publisher","first-page":"e1584\u2013604","DOI":"10.1542\/peds.2012-0974","article-title":"Interventions for preschool children at high risk for ADHD: a comparative effectiveness review","volume":"131","author":"Charach","year":"2013","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD013011.pub2-BIB0054|cit54","doi-asserted-by":"publisher","first-page":"g3769","DOI":"10.1136\/bmj.g3769","article-title":"Drug treatment for attention-deficit\/hyperactivity disorder and suicidal behaviour: register based study","volume":"348","author":"Chen","year":"2014","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD013011.pub2-BIB0055|cit55","doi-asserted-by":"publisher","first-page":"643","DOI":"10.2147\/NDT.S126438","article-title":"Trends, characteristics, and pharmacotherapy of adults diagnosed with attention-deficit hyperactivity disorder: a nationwide survey in Taiwan","volume":"13","author":"Cheng","year":"2017","journal-title":"Neuropsychiatric Disease and Treatment"},{"issue":"2","key":"10.1002\/14651858.CD013011.pub2-BIB0056|cit56","doi-asserted-by":"publisher","first-page":"130","DOI":"10.7326\/0003-4819-159-2-201307160-00008","article-title":"Conceptual and technical challenges in network meta-analysis","volume":"159","author":"Cipriani","year":"2013","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD013011.pub2-BIB0057|cit57","volume-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen","year":"1988"},{"issue":"9","key":"10.1002\/14651858.CD013011.pub2-BIB0058|cit58","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/S2215-0366(18)30269-4","article-title":"Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis","volume":"5","author":"Cortese","year":"2018","journal-title":"Lancet. Psychiatry"},{"key":"10.1002\/14651858.CD013011.pub2-BIB0059|cit59","unstructured":"Deeks JJ Higgins JP Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.1 (updated September 2020). Cochrane, 2020 Available from www.training.cochrane.org\/handbook"},{"issue":"10","key":"10.1002\/14651858.CD013011.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1007\/s002590000330","article-title":"Attention deficit hyperactivity disorder: binding of [99mTc]-TRODAT-1 to the dopamine transporter before and after methylphenidate treatment","volume":"27","author":"Dresel","year":"2000","journal-title":"European Journal of Nuclear Medicine"},{"issue":"7","key":"10.1002\/14651858.CD013011.pub2-BIB0061|cit61","doi-asserted-by":"publisher","first-page":"513","DOI":"10.7326\/M14-0933","article-title":"Financial conflicts of interest and conclusions about neuraminidase inhibitors for influenza: an analysis of systematic reviews","volume":"161","author":"Dunn","year":"2014","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD013011.pub2-BIB0062|cit62","unstructured":"Attention deficit hyperactivity disorder (ADHD) in adults: record number 231898 www.dynamed.com\/topics\/dmp~AN~T231898\/Attention-deficit-hyperactivity-disorder-ADHD-in-adults"},{"issue":"7109","key":"10.1002\/14651858.CD013011.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD013011.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD013011.pub2-BIB0065|cit65","unstructured":"European Medicines Agency Elements recommended for inclusion in summaries of product characteristics for methylphenidate-containing medicinal products authorised for the treatment of ADHD in children aged six years and above and adolescents www.ema.europa.eu\/docs\/en_GB\/document_library\/Referrals_document\/Methylphenidate_31\/WC500011184.pdf"},{"key":"10.1002\/14651858.CD013011.pub2-BIB0066|cit66","unstructured":"EndNote X8 Thomson Reuters 2017"},{"issue":"4","key":"10.1002\/14651858.CD013011.pub2-BIB0067|cit67","doi-asserted-by":"publisher","first-page":"322\u20138","DOI":"10.2174\/157015908787386069","article-title":"Dopaminergic and noradrenergic contributions to functionality in ADHD: the role of methylphenidate","volume":"6","author":"Engert","year":"2008","journal-title":"Current Neuropharmacology"},{"issue":"5","key":"10.1002\/14651858.CD013011.pub2-BIB0068|cit68","doi-asserted-by":"publisher","first-page":"455","DOI":"10.2217\/npy.13.59","article-title":"Changes in the definition of ADHD in DSM-5: subtle but important","volume":"3","author":"Epstein","year":"2013","journal-title":"Neuropsychiatry"},{"issue":"1","key":"10.1002\/14651858.CD013011.pub2-BIB0069|cit69","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s12402-016-0208-3","article-title":"The descriptive epidemiology of DSM-IV adult ADHD in the World Health Organization World Mental Health Surveys","volume":"9","author":"Fayyad","year":"2017","journal-title":"Attention Deficit and Hyperactivity Disorders"},{"issue":"10","key":"10.1002\/14651858.CD013011.pub2-BIB0070|cit70","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.euroneuro.2018.08.001","article-title":"Live fast, die young? A review on the developmental trajectories of ADHD across the lifespan","volume":"28","author":"Franke","year":"2018","journal-title":"European Neuropsychopharmacology"},{"issue":"6","key":"10.1002\/14651858.CD013011.pub2-BIB0071|cit71","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.euroneuro.2012.07.016","article-title":"Long-term efficacy and safety of treatment with stimulants and atomoxetine in adult ADHD: a review of controlled and naturalistic studies","volume":"23","author":"Fredriksen","year":"2013","journal-title":"European Neuropsychopharmacology"},{"issue":"5","key":"10.1002\/14651858.CD013011.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"e1001026","DOI":"10.1371\/journal.pmed.1001026","article-title":"Meta-analyses of adverse effects data derived from randomised controlled trials as compared to observational studies: methodological overview","volume":"8","author":"Golder","year":"2011","journal-title":"PLOS Medicine"},{"issue":"2","key":"10.1002\/14651858.CD013011.pub2-BIB0073|cit73","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1097\/00004583-200102000-00012","article-title":"Impairment and deportment responses to different methylphenidate doses in children with ADHD: the MTA titration trial","volume":"40","author":"Greenhill","year":"2001","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"10.1002\/14651858.CD013011.pub2-BIB0074|cit74","first-page":"217","volume-title":"ECDEU Assessment Manual for Psychopharmacology","author":"Guy","year":"1976"},{"key":"10.1002\/14651858.CD013011.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/1471-244X-11-176","article-title":"Comparative efficacy and acceptability of methylphenidate and atomoxetine in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis","volume":"11","author":"Hanwella","year":"2011","journal-title":"BMC Psychiatry"},{"issue":"9","key":"10.1002\/14651858.CD013011.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"713","DOI":"10.2165\/00023210-200620090-00002","article-title":"Methylphenidate and its isomers: their role in the treatment of attention-deficit hyperactivity disorder using a transdermal delivery system","volume":"20","author":"Heal","year":"2006","journal-title":"CNS Drugs"},{"key":"10.1002\/14651858.CD013011.pub2-BIB0077|cit77","unstructured":"Higgins JP Altman DG Sterne JAC Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.handbook.cochrane.org"},{"key":"10.1002\/14651858.CD013011.pub2-BIB0078|cit78","unstructured":"Higgins JP Eldridge S Chapter 23: Including variants on randomized trials. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.1 (updated September 2020). Cochrane, 2020 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD013011.pub2-BIB0079|cit79","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1471-244X-9-35","article-title":"Psychiatric and psychosocial problems in adults with normal-intelligence autism spectrum disorders","volume":"9","author":"Hofvander","year":"2009","journal-title":"BMC Psychiatry"},{"key":"10.1002\/14651858.CD013011.pub2-BIB0080|cit80","unstructured":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) Guideline for Good Clinical Practice E6(R2) www.ich.org\/page\/efficacy-guidelines"},{"issue":"19","key":"10.1002\/14651858.CD013011.pub2-BIB0081|cit81","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1001\/archinternmed.2009.313","article-title":"Adverse events in randomized trials: neglected, restricted, distorted, and silenced","volume":"169","author":"Ioannidis","year":"2009","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD013011.pub2-BIB0082|cit82","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13643-016-0259-8","article-title":"Evaluation of the Cochrane tool for assessing risk of bias in randomized clinical trials: overview of published comments and analysis of user practice in Cochrane and non-Cochrane reviews","volume":"5","author":"J\u00f8rgensen","year":"2016","journal-title":"Systematic Reviews"},{"key":"10.1002\/14651858.CD013011.pub2-BIB0083|cit83","unstructured":"Junqueira DR Age-dependent effects of methylphenidate on the human dopaminergic system in young vs adult patients with attention-deficit\/hyperactivity disorder [personal communication] Email to:\u00a0L\u00a0Reneman"},{"issue":"1","key":"10.1002\/14651858.CD013011.pub2-BIB0084|cit84","doi-asserted-by":"publisher","first-page":"77\u201384","DOI":"10.1038\/tpj.2013.9","article-title":"Meta-analysis of the association between dopamine transporter genotype and response to methylphenidate treatment in ADHD","volume":"14","author":"Kambeitz","year":"2014","journal-title":"Pharmacogenomics Journal"},{"issue":"4","key":"10.1002\/14651858.CD013011.pub2-BIB0085|cit85","doi-asserted-by":"publisher","first-page":"716\u201323","DOI":"10.1176\/ajp.2006.163.4.716","article-title":"The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication","volume":"163","author":"Kessler","year":"2006","journal-title":"American Journal of Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD013011.pub2-BIB0086|cit86","first-page":"389\u2013403","article-title":"Treatment of adults with attention-deficit hyperactivity disorder","volume":"4","author":"Kolar","year":"2008","journal-title":"Neuropsychiatric Disease and Treatment"},{"issue":"3","key":"10.1002\/14651858.CD013011.pub2-BIB0087|cit87","doi-asserted-by":"publisher","first-page":"e026478","DOI":"10.1136\/bmjopen-2018-026478","article-title":"Methodological advantages and disadvantages of parallel and crossover randomised clinical trials on methylphenidate for attention deficit hyperactivity disorder: a systematic review and meta-analyses","volume":"9","author":"Krogh","year":"2019","journal-title":"BMJ Open"},{"key":"10.1002\/14651858.CD013011.pub2-BIB0088|cit88","doi-asserted-by":"publisher","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD013011.pub2-BIB0089|cit89","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1503\/cmaj.141344","article-title":"If nothing happens, is everything all right? Distinguishing genuine reassurance from a false sense of security","volume":"187","author":"Loke","year":"2015","journal-title":"Canadian Medical Association Journal"},{"issue":"3","key":"10.1002\/14651858.CD013011.pub2-BIB0090|cit90","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1002\/jrsm.1310","article-title":"Dealing with effect size multiplicity in systematic reviews and meta-analyses","volume":"9","author":"L\u00f3pez-L\u00f3pez","year":"2018","journal-title":"Research Synthesis Methods"},{"issue":"2","key":"10.1002\/14651858.CD013011.pub2-BIB0091|cit91","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.MR000033.pub3","article-title":"Industry sponsorship and research outcome","author":"Lundh","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD013011.pub2-BIB0092|cit92","doi-asserted-by":"publisher","first-page":"j176","DOI":"10.1136\/bmj.j176","article-title":"The ties that bind","volume":"356","author":"Lundh","year":"2017","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD013011.pub2-BIB0093|cit93","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/1087054714559643","article-title":"Long-term efficacy of methylphenidate immediate-release for the treatment of childhood ADHD: a systematic review and meta-analysis","volume":"21","author":"Maia","year":"2017","journal-title":"Journal of Attention Disorders"},{"issue":"12","key":"10.1002\/14651858.CD013011.pub2-BIB0094|cit94","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1345\/aph.1D028","article-title":"Efficacy of stimulants in adult ADHD","volume":"37","author":"Maidment","year":"2003","journal-title":"Annals of Pharmacotherapy"},{"key":"10.1002\/14651858.CD013011.pub2-BIB0095|cit95","doi-asserted-by":"crossref","unstructured":"Maritime Pine medlineplus.gov\/druginfo\/natural\/1019.html","DOI":"10.1007\/978-1-4939-7131-2_364"},{"issue":"8","key":"10.1002\/14651858.CD013011.pub2-BIB0096|cit96","doi-asserted-by":"publisher","first-page":"1137\u201347","DOI":"10.1017\/S1461145709990198","article-title":"Pharmacotherapy of adult attention deficit hyperactivity disorder (ADHD): a meta-analysis","volume":"12","author":"M\u00e9sz\u00e1ros","year":"2009","journal-title":"International Journal of Neuropsychopharmacology"},{"issue":"10","key":"10.1002\/14651858.CD013011.pub2-BIB0097|cit97","doi-asserted-by":"publisher","first-page":"967\u201377","DOI":"10.1176\/appi.ajp.2015.14101266","article-title":"Is adult ADHD a childhood-onset neurodevelopmental disorder? Evidence from a four-decade longitudinal cohort study","volume":"172","author":"Moffitt","year":"2015","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD013011.pub2-BIB0098|cit98","doi-asserted-by":"publisher","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD013011.pub2-BIB0099|cit99","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Systematic Reviews"},{"issue":"9","key":"10.1002\/14651858.CD013011.pub2-BIB0100|cit100","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1192\/pb.bp.110.033423","article-title":"Critical analysis of the concept of adult attention-deficit hyperactivity disorder","volume":"35","author":"Moncrieff","year":"2011","journal-title":"Psychiatrist"},{"issue":"2","key":"10.1002\/14651858.CD013011.pub2-BIB0101|cit101","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1177\/1087054719866255","article-title":"Pharmacotherapy of ADHD in adults with autism spectrum disorder: effectiveness and side effects","volume":"24","author":"Muit","year":"2020","journal-title":"Journal of Attention Disorders"},{"key":"10.1002\/14651858.CD013011.pub2-BIB0102|cit102","unstructured":"National Institute for Health and Care Excellence Attention Deficit Hyperactivity Disorder: Diagnosis and Management (NG87); March 2018 (last updated September 2019) www.nice.org.uk\/guidance\/ng87"},{"key":"10.1002\/14651858.CD013011.pub2-BIB0103|cit103","unstructured":"National Institute of Mental Health Attention-deficit-hyperactivity disorder www.nimh.nih.gov\/health\/topics\/attention-deficit-hyperactivity-disorder-adhd\/index.shtml"},{"key":"10.1002\/14651858.CD013011.pub2-BIB0104|cit104","unstructured":"National Institute of Mental Health Could I have attention-deficit\/hyperactivity disorder (ADHD)? www.nimh.nih.gov\/health\/publications\/could-i-have-adhd\/index.shtml"},{"key":"10.1002\/14651858.CD013011.pub2-BIB0105|cit105","unstructured":"National Institute of Mental Health Research Domain Criteria (RDoC) www.nimh.nih.gov\/research\/research-funded-by-nimh\/rdoc\/about-rdoc.shtml"},{"key":"10.1002\/14651858.CD013011.pub2-BIB0106|cit106","unstructured":"Page MJ Higgins JP Sterne JA Chapter 13: Assessing risk of bias due to missing results in a synthesis. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.1 (updated September 2020). Cochrane, 2020 Available from www.training.cochrane.org\/handbook"},{"issue":"1","key":"10.1002\/14651858.CD013011.pub2-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1186\/s12888-020-02828-1","article-title":"Lifetime co-occurring psychiatric disorders in newly diagnosed adults with attention deficit hyperactivity disorder (ADHD) or\/and autism spectrum disorder (ASD)","volume":"20","author":"Pehlivanidis","year":"2020","journal-title":"BMC Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD013011.pub2-BIB0108|cit108","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1590\/S0034-8910.2014048005234","article-title":"Prescription, dispensation and marketing patterns of methylphenidate","volume":"48","author":"Perini","year":"2014","journal-title":"Revista de Sa\u00fade P\u00fablica"},{"key":"10.1002\/14651858.CD013011.pub2-BIB0109|cit109","volume-title":"Pharmaceutics - Drug Delivery and Targeting","author":"Perrie","year":"2012"},{"issue":"1","key":"10.1002\/14651858.CD013011.pub2-BIB0110|cit110","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00213-007-0996-4","article-title":"Comparative benefits and harms of competing medications for adults with attention-deficit hyperactivity disorder: a systematic review and indirect comparison meta-analysis","volume":"197","author":"Peterson","year":"2008","journal-title":"Psychopharmacology"},{"issue":"6","key":"10.1002\/14651858.CD013011.pub2-BIB0111|cit111","doi-asserted-by":"publisher","first-page":"942\u20138","DOI":"10.1176\/ajp.2007.164.6.942","article-title":"The worldwide prevalence of ADHD: a systematic review and metaregression analysis","volume":"164","author":"Polanczyk","year":"2007","journal-title":"American Journal of Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD013011.pub2-BIB0112|cit112","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1093\/ije\/dyt261","article-title":"ADHD prevalence estimates across three decades: an updated systematic review and meta-regression analysis","volume":"43","author":"Polanczyk","year":"2014","journal-title":"International Journal of Epidemiology"},{"issue":"3","key":"10.1002\/14651858.CD013011.pub2-BIB0113|cit113","doi-asserted-by":"publisher","first-page":"e002312","DOI":"10.1136\/bmjopen-2012-002312","article-title":"Long-acting versus short-acting methylphenidate for paediatric ADHD: a systematic review and meta-analysis of comparative efficacy","volume":"3","author":"Punja","year":"2013","journal-title":"BMJ Open"},{"issue":"2","key":"10.1002\/14651858.CD013011.pub2-BIB0114|cit114","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009996.pub2","article-title":"Amphetamines for attention deficit hyperactivity disorder (ADHD) in children and adolescents","author":"Punja","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1002\/14651858.CD013011.pub2-BIB0115|cit115","doi-asserted-by":"publisher","first-page":"2435\u201341","DOI":"10.1007\/s10803-013-1793-z","article-title":"Systematic review and meta-analysis of pharmacological treatment of the symptoms of attention-deficit\/hyperactivity disorder in children with pervasive developmental disorders","volume":"43","author":"Reichow","year":"2013","journal-title":"Journal of Autism and Developmental Disorders"},{"key":"10.1002\/14651858.CD013011.pub2-BIB0116|cit116","doi-asserted-by":"publisher","first-page":"g6501","DOI":"10.1136\/bmj.g6501","article-title":"Selective reporting bias of harm outcomes within studies: findings from a cohort of systematic reviews","volume":"349","author":"Saini","year":"2014","journal-title":"BMJ"},{"issue":"44","key":"10.1002\/14651858.CD013011.pub2-BIB0117|cit117","doi-asserted-by":"publisher","first-page":"14769","DOI":"10.1523\/JNEUROSCI.1560-14.2014","article-title":"Acute and sustained effects of methylphenidate on cognition and presynaptic dopamine metabolism: an [18F]FDOPA PET study","volume":"34","author":"Schabram","year":"2014","journal-title":"Journal of Neuroscience"},{"issue":"8","key":"10.1002\/14651858.CD013011.pub2-BIB0118|cit118","doi-asserted-by":"publisher","first-page":"e1002101","DOI":"10.1371\/journal.pmed.1002101","article-title":"Assessment of adverse events in protocols, clinical study reports, and published papers of trials of Orlistat: a document analysis","volume":"13","author":"Schroll","year":"2016","journal-title":"PLOS Medicine"},{"key":"10.1002\/14651858.CD013011.pub2-BIB0119|cit119","unstructured":"Sch\u00fcnemann HJ Higgins JP Vist GE Glasziou P Akl EA Skoetz N Chapter 14: Completing \u2018Summary of findings\u2019 tables and grading the certainty of the evidence. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.1 (updated September 2020). Cochrane, 2020 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD013011.pub2-BIB0120|cit120","unstructured":"Schu\u0308nemann HJ Vist GE Higgins JP Santesso N Deeks JJ Glasziou P Chapter 15: Interpreting results and drawing conclusions. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.1 (updated September 2020). Cochrane, 2020 Available from www.training.cochrane.org\/handbook."},{"issue":"12","key":"10.1002\/14651858.CD013011.pub2-BIB0121|cit121","doi-asserted-by":"publisher","first-page":"1157\u201365","DOI":"10.1016\/S2215-0366(16)30190-0","article-title":"Method of adult diagnosis influences estimated persistence of childhood ADHD: a systematic review of longitudinal studies","volume":"3","author":"Sibley","year":"2016","journal-title":"Lancet Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD013011.pub2-BIB0122|cit122","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1023\/B:QURE.0000018486.91360.00","article-title":"The World Health Organization's WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL group","volume":"13","author":"Skevington","year":"2004","journal-title":"Quality of Life Research"},{"key":"10.1002\/14651858.CD013011.pub2-BIB0123|cit123","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jneumeth.2015.02.002","article-title":"Effect of methylphenidate treatment during adolescence on norepinephrine transporter function in orbitofrontal cortex in a rat model of attention deficit hyperactivity disorder","volume":"252","author":"Somkuwar","year":"2015","journal-title":"Journal of Neuroscience Methods"},{"issue":"6","key":"10.1002\/14651858.CD013011.pub2-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1001\/archpsyc.1995.03950180020004","article-title":"A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder","volume":"52","author":"Spencer","year":"1995","journal-title":"Archives of General Psychiatry"},{"issue":"4 Pt 1","key":"10.1002\/14651858.CD013011.pub2-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1542\/peds.98.4.748","article-title":"Methylphenidate dosing: twice daily versus three times daily","volume":"98","author":"Stein","year":"1996","journal-title":"Pediatrics"},{"issue":"11","key":"10.1002\/14651858.CD013011.pub2-BIB0126|cit126","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009885.pub2","article-title":"Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)","author":"Storeb\u00f8","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD013011.pub2-BIB0127|cit127","volume-title":"Martindale: The Complete Drug Reference","author":"Sweetman","year":"2014"},{"issue":"1","key":"10.1002\/14651858.CD013011.pub2-BIB0128|cit128","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1471-2288-14-30","article-title":"Which is more generalizable, powerful and interpretable in meta-analyses, mean difference or standardized mean difference?","volume":"14","author":"Takeshima","year":"2014","journal-title":"BMC Medical Research Methodology"},{"issue":"4","key":"10.1002\/14651858.CD013011.pub2-BIB0129|cit129","doi-asserted-by":"publisher","first-page":"e994","DOI":"10.1542\/peds.2014-3482","article-title":"Prevalence of attention-deficit hyperactivity disorder: a systematic review and meta-analysis","volume":"135","author":"Thomas","year":"2015","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD013011.pub2-BIB0130|cit130","first-page":"262","volume-title":"Nelson Textbook of Pediatrics","volume":"2","author":"Urion","year":"2020"},{"key":"10.1002\/14651858.CD013011.pub2-BIB0131|cit131","unstructured":"FDA directs ADHD drug manufacturers to notify patients about cardiovascular adverse events and psychiatric adverse events tinyurl.com\/yxltwhwy"},{"issue":"5","key":"10.1002\/14651858.CD013011.pub2-BIB0132|cit132","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1001\/jamapsychiatry.2017.0298","article-title":"The World Health Organization Adult Attention-Deficit Hyperactivity Disorder Self-report Screening Scale for DSM-5","volume":"74","author":"Ustun","year":"2017","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD013011.pub2-BIB0133|cit133","doi-asserted-by":"publisher","first-page":"RC121","DOI":"10.1523\/JNEUROSCI.21-02-j0001.2001","article-title":"Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain","volume":"21","author":"Volkow","year":"2001","journal-title":"Journal of Neuroscience"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD013011.pub2-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1177\/070674370200601S05","article-title":"Mechanism of action of methylphenidate: insights from PET imaging studies","volume":"6","author":"Volkow","year":"2002","journal-title":"Journal of Attention Disorders"},{"key":"10.1002\/14651858.CD013011.pub2-BIB0135|cit135","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1146\/annurev-clinpsy-032814-112800","article-title":"Diagnostic issues and controversies in DSM-5: return of the false positives problem","volume":"12","author":"Wakefield","year":"2016","journal-title":"Annual Review of Clinical Psychology"},{"issue":"3","key":"10.1002\/14651858.CD013011.pub2-BIB0136|cit136","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/00005650-199603000-00003","article-title":"A 12-item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity","volume":"34","author":"Kosinski","year":"1996","journal-title":"Medical Care"},{"issue":"2","key":"10.1002\/14651858.CD013011.pub2-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"382\u221286","DOI":"10.1016\/S0022-3565(25)21542-7","article-title":"Pharmacokinetics of methylphenidate in man, rat and monkey","volume":"226","author":"Wargin","year":"1983","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1002\/14651858.CD013011.pub2-BIB0138|cit138","volume-title":"The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines","author":"World Health Organization","year":"1992"},{"key":"10.1002\/14651858.CD013011.pub2-BIB0139|cit139","unstructured":"WHO Collaborating Centre for Drug Statistic Methodology ATC\/DDD Index 2020 www.whocc.no\/atcddd"},{"key":"10.1002\/14651858.CD013011.pub2-BIB0140|cit140","volume-title":"ICD-11: International Classification of Diseases for Mortality and Morbidity Statistics, Eleventh Revision","author":"World Health Organization","year":"2018"},{"issue":"1","key":"10.1002\/14651858.CD013011.pub2-BIB0141|cit141","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1744-9081-6-34","article-title":"Randomized, double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit\/hyperactivity disorder: novel findings using a simulated adult workplace environment design","volume":"6","author":"Wigal","year":"2010","journal-title":"Behavioral and Brain Functions"},{"issue":"22","key":"10.1002\/14651858.CD013011.pub2-BIB0142|cit142","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.2165\/00003495-200363220-00002","article-title":"Drug therapy for adults with attention-deficit hyperactivity disorder","volume":"63","author":"Wilens","year":"2003","journal-title":"Drugs"},{"issue":"4","key":"10.1002\/14651858.CD013011.pub2-BIB0143|cit143","doi-asserted-by":"publisher","first-page":"e20192528. Erra","DOI":"10.1542\/peds.2019-2528","article-title":"Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit\/hyperactivity disorder in children and adolescents","volume":"144","author":"Wolraich","year":"2019","journal-title":"Pediatrics"},{"issue":"1","key":"10.1002\/14651858.CD013011.pub2-BIB0144|cit144","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1124\/pr.112.007054","article-title":"Psychostimulants and cognition: a continuum of behavioral and cognitive activation","volume":"66","author":"Wood","year":"2013","journal-title":"Pharmacological Reviews"},{"issue":"4","key":"10.1002\/14651858.CD013011.pub2-BIB0145|cit145","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013011","article-title":"Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults","author":"C\u00e2ndido","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T11:19:53Z","timestamp":1760613593000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD013011.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Developmental, Psychosocial and Learning Problems Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,1,18]]},"references-count":145,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,1]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd013011.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,18]]}}}